Synthetic eye drops have been unable to mimic the effectiveness of normal tear film for severe dry eye disease patients. Vidaris autologous serum eye drops (ASED) are derived from the patient’s own blood serum and contain many of the same biochemical properties so they are able to nourish the eye like natural tears. ASED can improve the epithelial surface environment of the eye and provide the corneal surface with the chemotactic factors, nutrients, and growth factors necessary for proliferation and therapeutic effect in ocular surface disorders.


We can process different concentrations based on your patients needs. As a non-profit, we make this therapy an economical option for your patient.


Our staff will coordinate blood draw, billing and delivery once treatment is prescribed.


Every batch of eye drops undergoes a 14-day fungal and bacterial culture to ensure sterility prior to distribution to the patient.


Our processing method underwent rigorous validations to ensure stability and safety under the recommended storage conditions. The eye drops are processed in an ISO 5 environment, meeting or exceeding industry standards.  

Provide Vidaris to your Patients

12 + 5 =